Journal of Diabetes Investigation (Sep 2023)

Weight loss improves inflammation by T helper 17 cells in an obese patient with psoriasis at high risk for cardiovascular events

  • Yoshiro Maezawa,
  • Yusuke Endo,
  • Satomi Kono,
  • Tomohiro Ohno,
  • Yuumi Nakamura,
  • Naoya Teramoto,
  • Ayano Yamaguchi,
  • Kazuto Aono,
  • Takuya Minamizuka,
  • Hisaya Kato,
  • Takahiro Ishikawa,
  • Masaya Koshizaka,
  • Minoru Takemoto,
  • Toshinori Nakayama,
  • Koutaro Yokote

DOI
https://doi.org/10.1111/jdi.14037
Journal volume & issue
Vol. 14, no. 9
pp. 1136 – 1139

Abstract

Read online

Abstract Psoriasis is a chronic inflammatory skin disease that is associated with obesity and myocardial infarction. Obesity‐induced changes in lipid metabolism promote T helper 17 (Th17) cell differentiation, which in turn promotes chronic inflammation. Th17 cells have central roles in many inflammatory diseases, including psoriasis and atherosclerosis; however, whether treatment of obesity attenuates Th17 cells and chronic inflammatory diseases has been unknown. In this study, we found an increase in Th17 cells in a patient with obesity, type 2 diabetes and psoriasis. Furthermore, weight loss with diet and exercise resulted in a decrease in Th17 cells and improvement of psoriasis. This case supports the hypothesis that obesity leads to an increase in Th17 cells and chronic inflammation of the skin and blood vessel walls, thereby promoting psoriasis and atherosclerosis.

Keywords